August 29, 2011— The echocardiographic response (reduction of left ventricular end-systolic volume), evaluated at six months follow-up, proved a better predictor of long-term mortality than clinical status improvement in a large population of cardiac resychronization therapy (CRT) patients. Therefore, assessment of occurrence of left ventricular reverse remodeling at mid-term follow-up may be an adequate surrogate endpoint in heart failure patients treated with CRT.

August 29, 2011 – BK Medical will showcase its innovative Flex Focus 700 ultrasound system and BK Power Pack at the 13th World Congress of the World Federation for Ultrasound in Medicine and Biology (WFUMB) in Vienna, Austria, Aug. 26-29, 2011.

 

August 29, 2011 — Recent data suggest post-operative outcomes of severe heart failure patients bridged short-term ventricular assist devices (VADs) to urgent heart transplantation are significantly worse than in patients bridged with conventional support. The data comes from the Spanish National Heart Transplant Registry.

Stroke patients who need emergency care should be taken to the nearest certified primary stroke center, which acts as a central point for stroke treatment, according to recommendations from the Brain Attack Coalition (BAC), a group representing medical, scientific, nonprofit and government leaders in the field of stroke. The recommendations, which reflect advances in stroke treatment over the past decade, are published online in the September issue of the journal Stroke.

August 29, 2011 — The Guidelines on Peripheral Artery Disease (PAD) are the first document produced by the European Society of Cardiology (ESC) to address all aspects of peripheral atherosclerotic disease, excepting the aorta. The document does include disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. It is the result of close collaboration between physicians from many different areas of expertise: cardiology, neurology, radiology, vascular surgery, and vascular medicine.

The U.S. Food and Drug Administration (FDA) recently released its “Strategic Plan for Regulatory Science,” a sweeping initiative to modernize the tools and methods that the agency uses to evaluate whether the products it regulates are effective and safe for consumers.


August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro investment in the company to accelerate its device development and bring it to market. The European company develops medical implants to treat structural heart disease such as atrial septal defects and patent foramen ovale (ASD and PFO) and left atrial appendage (LAA) occluders.


August 25, 2011 – Two articles in the Society of Interventional Radiology (SIR)'s flagship publication, the Journal of Vascular and Interventional Radiology, report on studies related to peripheral arterial disease (PAD), coinciding with the approach of September's National PAD Awareness Month.

Subscribe Now